Literature DB >> 16299339

Intrapulmonary, adenovirus-mediated overexpression of KARAP/DAP12 enhances fungal clearance during invasive aspergillosis.

Kristin J Carpenter1, Karen F Buckland, Zhou Xing, Cory M Hogaboam.   

Abstract

Herein, we report that the intrapulmonary delivery of an adenovirus vector expressing KARAP/DAP12, an adaptor protein expressed in granulocytes and mononuclear cells, enhanced fungal clearance during experimental invasive pulmonary aspergillosis in neutropenic mice.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16299339      PMCID： PMC1307040          DOI： 10.1128/IAI.73.12.8402-8406.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  37 in total

1.  Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes.

Authors:  A Bouchon; J Dietrich; M Colonna
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  The role of the DAP12 signal in mouse myeloid differentiation.

Authors:  N Aoki; S Kimura; Y Takiyama; Y Atsuta; A Abe; K Sato; M Katagiri
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

3.  DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming.

Authors:  A B Bakker; R M Hoek; A Cerwenka; B Blom; L Lucian; T McNeil; R Murray; L H Phillips; J D Sedgwick; L L Lanier
Journal:  Immunity       Date:  2000-09       Impact factor: 31.745

4.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock.

Authors:  A Bouchon; F Facchetti; M A Weigand; M Colonna
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

5.  CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.

Authors:  B Mehrad; R M Strieter; T A Moore; W C Tsai; S A Lira; T J Standiford
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

6.  Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response.

Authors:  A Matsukawa; C M Hogaboam; N W Lukacs; P M Lincoln; H L Evanoff; S L Kunkel
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

Review 7.  The pathobiology of Aspergillus fumigatus.

Authors:  J P Latgé
Journal:  Trends Microbiol       Date:  2001-08       Impact factor: 17.079

8.  Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.

Authors:  J Paloneva; M Kestilä; J Wu; A Salminen; T Böhling; V Ruotsalainen; P Hakola; A B Bakker; J H Phillips; P Pekkarinen; L L Lanier; T Timonen; L Peltonen
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

9.  Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.

Authors:  Serge Nataf; Adrienne Anginot; Carine Vuaillat; Luc Malaval; Nassima Fodil; Emmanuel Chereul; Jean-Baptiste Langlois; Christiane Dumontel; Gaelle Cavillon; Christian Confavreux; Marlène Mazzorana; Laurence Vico; Marie-Franaçoise Belin; Eric Vivier; Elena Tomasello; Pierre Jurdic
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

10.  A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.

Authors:  A Bouchon; C Hernández-Munain; M Cella; M Colonna
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307
View more
  2 in total

1.  Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice.

Authors:  Glendie Marcelin; Jerry R Aldridge; Susu Duan; Hazem E Ghoneim; Jerold Rehg; Henju Marjuki; Adrianus C M Boon; Jonathan A McCullers; Richard J Webby
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

2.  Triggering receptor expressed on myeloid cells-1 (TREM-1) modulates immune responses to Aspergillus fumigatus during fungal asthma in mice.

Authors:  Karen F Buckland; Hemanth Ramaprakash; Lynne A Murray; Kristin J Carpenter; Esther S Choi; Steven L Kunkel; Nicholas W Lukacs; Zhou Xing; Naoko Aoki; Dominik Hartl; Cory M Hogaboam
Journal:  Immunol Invest       Date:  2011-05-19       Impact factor: 3.657
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.